[{"abstract": "Companies are pouring billions into developing cancer drugs, lured by the high prices such drugs can command.", "web_url": "https://www.nytimes.com/2009/09/02/health/research/02cancerdrug.html", "snippet": "Companies are pouring billions into developing cancer drugs, lured by the high prices such drugs can command.", "lead_paragraph": "SAN DIEGO \u0097 Pfizer\u2019s fortunes in the past were built on cardiovascular drugs, like the cholesterol buster Lipitor and the blood pressure pill Norvasc. ", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2009/09/02/business/02cancerdrug_75.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2009/09/02/business/02cancerdrug_75.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "For Profit, Industry Seeks Cancer Drugs", "kicker": "Forty Years' War", "content_kicker": null, "print_headline": "Taking Big Risk for Big Payoff, Industry Seeks Cancer Drugs", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Cancer", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 4, "major": "N"}, {"name": "subject", "value": "Research", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Exelixis Incorporated", "rank": 6, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 7, "major": "N"}], "pub_date": "2009-09-02T01:21:49+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "subsection_name": "Research", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "Series", "_id": "nyt://article/2ff2563b-109d-52dd-b90c-4e5c3914ff77", "word_count": 1832, "uri": "nyt://article/2ff2563b-109d-52dd-b90c-4e5c3914ff77"}, {"abstract": "The government charged that executives throughout the company planned schemes to illegally market Bextra and other drugs.", "web_url": "https://www.nytimes.com/2009/09/03/business/03health.html", "snippet": "The government charged that executives throughout the company planned schemes to illegally market Bextra and other drugs.", "lead_paragraph": "WASHINGTON \u0097 The pharmaceutical giant Pfizer agreed to pay $2.3 billion to settle civil and criminal allegations that it had illegally marketed its painkiller Bextra, which has been withdrawn.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Pays $2.3 Billion to Settle Marketing Case", "kicker": null, "content_kicker": null, "print_headline": "Pfizer to Pay $2.3 Billion to Settle Inquiry Over Marketing", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Bextra (Drug)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Frauds and Swindling", "rank": 4, "major": "N"}, {"name": "subject", "value": "ADVERTISING AND MARKETING", "rank": 5, "major": "N"}], "pub_date": "2009-09-02T14:38:10+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Gardiner Harris", "person": [{"firstname": "Gardiner", "middlename": null, "lastname": "Harris", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cae7074f-c51e-539c-9e67-86c73465a47e", "word_count": 1075, "uri": "nyt://article/cae7074f-c51e-539c-9e67-86c73465a47e"}]